Up to 44% of people starting semaglutide or tirzepatide experience nausea, especially during the first 4–8 weeks or after each dose increase. The good news: nausea almost always improves once your body adapts. The challenge is getting through those early weeks without abandoning treatment.
GLP-1 receptor agonists slow gastric emptying — food moves out of your stomach more slowly than usual. When combined with eating at your usual pace and portion size, this delay creates a backed-up, overfull sensation that triggers nausea. The brain's vomiting centre also has GLP-1 receptors, so there's a direct central component too.
This is the single most effective change you can make. Cut your usual meal size in half and extend eating time to 15–20 minutes. Put your fork down between bites. Eating past the point of satisfaction is a near-guaranteed trigger for nausea on GLP-1.
During the adaptation period, choose foods that are easy to digest and low in fat (fat slows gastric emptying further).
Many people find injecting at bedtime reduces nausea because they sleep through the peak effect. Others prefer morning injections so nausea peaks during the day when they can manage it consciously. Try both and see which works for you. Consistency in timing (same day, same time) also helps your body anticipate and adapt.
Contact your prescriber if you cannot keep fluids down for more than 24 hours, lose significant weight due to inability to eat, or experience severe vomiting. A dose reduction or slower titration schedule can make all the difference.
Getting 100g+ of protein daily on a reduced appetite is hard. Strategic timing makes it more achievable — and more effective for muscle preservation.
Medication helps with appetite. But the mental skills for sustainable weight management — resilience, flexibility, self-compassion — must be built intentionally.
People who share their journey with a community — online or in person — consistently achieve better outcomes. Here's why, and where to find yours.